Overview

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients

Status:
NOT_YET_RECRUITING

Trial end date:
2029-01-15

Target enrollment:

Participant gender:

Summary

Phase III, open label, randomised, multicentre, blind for evaluators clinical trial to evaluate the efficacy of esketamine nasal spray at flexible dosis compared to aripiprazole in elderly participants (\>60 years) who suffer from treatment-resistant major depressive

Phase:

PHASE3

Details

Lead Sponsor:

Fundacin Pblica Andaluza para la gestin de la Investigacin en Sevilla